The healthcare industry generates 30% of the world’s data volume, with phase 3 clinical trials generating ~3.6 million data points on average. This means clinical trial sponsors are uniquely positioned to lead when it comes to safely using sensitive data to transform innovation and human achievement.
Data anonymization is key to unlocking the value of sensitive data for sharing and secondary uses. But concerns around the loss of data utility, lack of scalability, and regulatory compliance unnecessarily hold many data leaders back from realizing their full potential.
In this webinar, Thomasin Element, Head of Technology Customer Success and Partnerships at Privacy Analytics, walks you through the benefits of statistical anonymization, its superiority over redaction, and the 5 ways AI can help you accelerate data sharing and reuse.